175 Results for "

PTP1B

" in MedChemExpress (MCE) Product Catalog:
Products (175)

175 Results for "PTP1B" in MCE Product Catalog:

Cat. No.: HY-P1799A
Target:  

Phosphatase

Research Areas:  

Others

[pTyr5] EGFR (988-993) TFA is derived from the autophosphorylation site (Tyr992) of epidermal growth factor receptor (EGFR 988-993). [pTyr5] EGFR (988-993) TFA is often complexed with the catalytically inactive protein-tyrosine phosphate 1B (PTP1B) [1].
loading...
    loading...
Cat. No.: HY-111469R
CAS No.: 888213-72-7
Research Areas:  

Metabolic Disease

CPT-157633 (Standard) is the analytical standard of CPT-157633 (HY-111469). This product is intended for research and analytical applications. CPT-157633, a difluoro-phosphonomethyl phenylalanine derivative, and is a PTP1B inhibitor. CPT-157633 prevents binge drinKing-induced glucose intolerance [1].
loading...
    loading...
Cat. No.: HY-163899
(+)-Crinatusin A1 (Compound (+)- 4) is a chalcone-monoterpene hybrid, which can be isolated from Cleistocalyx operculatus. (+)-Crinatusin A1 is an inhibitor for protein tyrosine phosphatase 1B (PTP1B) with IC50 of 0.9 μM. (+)-Crinatusin A1 exhibits potential as an antidiabetic agent [1].
loading...
    loading...
Cat. No.: HY-N12915
CAS No.: 2130080-86-1
SHP2-IN-29 (Compound 3) is a potent SHP2 inhibitor with an IC50 value of 0.18 μM. SHP2-IN-29 also has inhibitory activity against PTP1B and TCPTP, with IC50 values of 4.27 and 4.74 μM, respectively.
loading...
    loading...
Cat. No.: HY-135564B
CAS No.: 154639-24-4
Target:  

Phosphatase

Research Areas:  

Cancer

(Rac)-RK-682, a racemate of RK-682, is a protein tyrosine phosphatases (PTPases) inhibitor. (Rac)-RK-682 inhibits protein tyrosine phosphatase 1B (PTP-1B), low molecular weight protein tyrosine phosphatases (LMW-PTP), and cell division cycle 25B (CDC-25B) with IC50s of 8.6 μM, 12.4 μM, and 0.7 μM, respectively [1].
loading...
    loading...
Cat. No.: HY-164425
CAS No.: 2597832-98-7
Target:  

Phosphatase STAT

Research Areas:  

Metabolic Disease

ENT-03 is a centrally acting mammalian aminosterol. ENT-03 upregulates cFos activation, inhibits PTP1b and induces phosphorylation of STAT3. ENT-03 normalizes blood glucose, induces weight loss. ENT-03 can be used in the research of type 2 diabetes and obesity [1].
loading...
    loading...
Cat. No.: HY-N18421
CAS No.: 13192-07-9
4',7-Dihydroxy-3'-methoxyflavanone is a protein tyrosine phosphatase 1B (PTP1B) inhibitor, with an IC50 of 98.1 μM against human targets. 4',7-Dihydroxy-3'-methoxyflavanone can be used in research related to type 2 diabetes and obesity [1].
loading...
    loading...
Cat. No.: HY-122416
CAS No.: 68236-11-3
Synonyms: Lonchocarpol A; Senegalensin
6,8-Diprenylnaringenin (Lonchocarpol A; Senegalensin) is a potent BCRP/ABCG2 inhibitor (IC50 = 0.410 μM) and a non-competitive allosteric PTP1B inhibitor (IC50 = 1.04 μM; Ki = 1.56 μM) that is isolated from Humulus lupulus. 6,8-Diprenylnaringenin produces non-competitive allosteric inhibition by locking the WPD catalytic loop of PTP1B in an inactive open conformation, while simultaneously binding to and inhibiting the ABCG2 drug efflux pump. 6,8-Diprenylnaringenin also exhibits antibacterial activity against MRSA (MIC = 6-13 μM) and antioxidant activity. 6,8-Diprenylnaringenin is used in research on type 2 diabetes, obesity, MRSA infection, and atherosclerosis [1] .
loading...
    loading...
Cat. No.: HY-160550
CAS No.: 3018836-86-4
Target:  

Phosphatase CXCR

Research Areas:  

Inflammation/Immunology

DPM-1003 is a modulator of protein tyrosine phosphatase 1B (PTP1B) and C-X-C chemokine receptor 4 (CXCR4). DPM-1003 binds to the non-catalytic disordered C-terminal fragment of PTP1B. DPM-1003 inhibits the PI3Kγ-mediated AKT/mTOR signaling pathway downstream of CXCR4. DPM-1003 improves the survival rate of mice in a transfusion-related acute lung injury model, and exerts a lung injury protective effect in preclinical mouse models of acute lung injury and sepsis. DPM-1003 can be used in research related to acute lung injury, acute respiratory distress syndrome, transfusion-related acute lung injury and sepsis [1].
loading...
    loading...
Cat. No.: HY-160514
CAS No.: 2097148-94-0
Target:  

Phosphatase

Research Areas:  

Metabolic Disease

LXQ46 is an orally active inhibitor for protein tyrosine phosphatase 1B (PTP1B), with an IC50 of 0.190 μM. LXQ46 enhances insulin and leptin signaling pathways in insulin-resistant C2C12. LXQ46 ameliorates type 2 diabetes and increases insulin tolerance in mouse models [1].
loading...
    loading...
Cat. No.: HY-N12177
CAS No.: 1647101-05-0
Cryptosporioptide A (Compound 3) is a pigment protein tyrosine phosphatase inhibitor derived from the insect-parasitic fungus Cordyceps gracilioides. Cryptosporioptide A inhibits PTP1B, SHP2, CDC25B, LAR and SHP1 enzymes with IC50 of 7.3, 5.7, 7.6, >50, 4.9 μg/mL, respectively [1].
loading...
    loading...
Cat. No.: HY-N12761
Penpaxilloids A (Compound 1) is a non-competitive inhibitor of protein tyrosine phosphatase 1B (PTP1B) with an IC50 value of 8.60 μM. Penpaxilloids A can be isolated from the fungus Penicillium sp. ZYX-Z-143. Penpaxilloids A is also an α-glucosidase (α-glucosidase) inhibitor with anti-inflammatory activity [1].
loading...
    loading...
Cat. No.: HY-N3734
CAS No.: 27468-20-8
Deoxyneocryptotanshinone, a natural tanshinone, is a high affinity BACE1 (Beta-secretase) inhibitor with an IC50 value of 11.53 μM. Deoxyneocryptotanshinone shows a promising dose-dependent inhibition of protein tyrosine phosphatase 1B (PTP1B) with an IC50 value of 133.5 μM. Deoxyneocryptotanshinone can be used for Alzheimer's disease research [1] .
loading...
    loading...
Cat. No.: HY-120159
CAS No.: 1710337-31-7
Target:  

SHP2 SHP1 Phosphatase

Research Areas:  

Cancer

GS-493 is a selective protein tyrosine phosphatase SHP2 (PTPN11) inhibitor with an IC50 of 71 nM. GS-493 is 29- and 45-fold more active toward SHP2 than related SHP1 and PTP1B. GS-493 blocks cellular motility and growth of cancer cells. Antitumor activity [1].
loading...
    loading...
Cat. No.: HY-182463
CAS No.: 173792-68-2
Moreollic acid is a PTP1B inhibitor, with an IC50 of 4.44 μM and a Ki of 1.75 μM against human targets. Moreollic acid blocks cell cycle progression from the G1 to S phase and inhibits tumor cell proliferation. Moreollic acid can be used in research related to type 2 diabetes, obesity, colon cancer and other cancers [1] .
loading...
    loading...
Cat. No.: HY-N17601
CAS No.: 50277-02-6
Parvisoflavone B is a prenylated flavonoid. Parvisoflavone B can be isolated from root bark of Erythrina mildbraedii. Parvisoflavone B inhibits PTP1B activity with an IC50 of 42.6 μM. Parvisoflavone B inhibits α-glucosidase with an IC50 of 12.19 μM. Parvisoflavone B can be used in the research of type 2 diabetes and obesity [1] .
loading...
    loading...
Cat. No.: HY-N7165
CAS No.: 69297-40-1
3-O-cis-p-Coumaroyl maslinic acid (compound 16) is a natural compound isolated from the ethyl acetate extract of leaves of Miconia albicans.3-O-cis-p-Coumaroyl maslinic acid can inhibit PTP1B, with the IC50 of 0.46 μM, and shows antimicrobial activity on Gram-positive bacteria and yeasts [1] .
loading...
    loading...
Cat. No.: HY-118567
CAS No.: 38213-69-3
Purity:  99.34%
Synonyms: BMOV
Target:  

SHP2 Phosphatase

Research Areas:  

Metabolic Disease

Bis(maltolato)oxovanadium(IV) (BMOV) is a potent, reversible, competitive and orally active pan-PTP (protein tyrosine phosphatases) inhibitor. Bis(maltolato)oxovanadium(IV) inhibits HCPTPA, PTP1B, HPTPβ and SHP2 with IC50s of 126 nM, 109 nM, 26 nM and 201 nM, respectively. Bis(maltolato)oxovanadium(IV) is a potent insulin sensitizer [1] .
loading...
    loading...
Cat. No.: HY-157673
CAS No.: 61599-23-3
Synonyms: 16:1 PE
Target:  

Phosphatase Apoptosis

Research Areas:  

Cancer

1,2-Dipalmitoleoyl-sn-glycero-3-phosphoethanolamine (16:1 PE) is a phosphatidylethanolamine that can enhance PP2A and PTP1B activities in malignant pleural mesothelioma cells. 1,2-Dipalmitoleoyl-sn-glycero-3-phosphoethanolamine induces apoptosis of NCI-H28 malignant pleural mesothelioma cells [1].
loading...
    loading...
Cat. No.: HY-181683
Research Areas:  

Metabolic Disease

Antidiabetic agent 8 is an orally active multi-target inhibitor, with IC50 values of 9.79, 6.36 and 19.08 μM against α-glucosidase, α-amylase and PTP1B, respectively. Antidiabetic agent 8 reduces postprandial blood glucose elevation. Antidiabetic agent 8 can be used in the research of type 2 diabetes [1].
loading...
    loading...